Lifecore's CEO, Paul Josephs, discusses positive feedback from pharma customers on fiscal '25 plans, focusing on pipeline growth and tech transfer projects. CFO Ryan Lake addresses gross margins, new equipment impact, and total debt of around $160 million.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing